|
|
|
Corporate Profile: KMT Hepatech
| Summary: |
KMT Hepatech is focused on providing in vivo research services to companies who are in preclinical development of Hepatitis C (HCV), Hepatitis B (HBV) and Malaria therapeutics and vaccines, utilizing a transgenic mouse with a humanized liver.
|
| Address (HQ): |
11421 Saskatchewan Drive
Edmonton, AB
Canada, T6G 2M9
|
| Phone
#'s (HQ): |
| Main |
(780) 641-1919 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(780) 641-1916 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
